Progyny, Inc.
Business
Progyny, Inc. is a benefits management company that provides employer-sponsored fertility, family building and women’s health benefits. It offers proprietary Smart Cycle treatment bundles, concierge Patient Care Advocates, an integrated pharmacy solution (Progyny Rx), preconception/maternity/postpartum and menopause care, provider network management, data reporting and reimbursement assistance programs. The company operates through its fertility benefits solution, an integrated pharmacy benefits offering, a selective national provider network, and client success/implementation services. Progyny serves large U.S. employers and their employees and dependents via employer-contracted, pre-tax health plan integrations and a nationwide specialist network.
Summary from filing dated 2025-03-03
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 1,289 | 1,167 | 1,089 | 787 | 501 | |
| Cost of services | 984 | 914 | 850 | 620 | 388 | |
| Gross profit | 304 | 253 | 239 | 167 | 112 | |
| Sales and marketing | 72 | 64 | 59 | 46 | 20 | |
| General and administrative | 147 | 122 | 117 | 98 | 60 | |
| Total operating expenses | 219 | 186 | 177 | 144 | 80 | |
| Income from operations | 85 | 67 | 62 | 23 | 32 | |
| Interest and other income, net | 10 | 16 | 9 | 1 | −366,000 | |
| Income before income taxes | 95 | 83 | 71 | 24 | 32 | |
| Provision for income taxes | 37 | 29 | 9 | −6 | −33 | |
| Net income | 59 | 54 | 62 | 30 | 66 | |
| Basic (in dollars per share) | 0.68 | 0.59 | 0.65 | 0.33 | 0.74 | |
| Diluted (in dollars per share) | 0.65 | 0.57 | 0.62 | 0.3 | 0.66 | |
| Basic (in shares) | 86 | 91 | 95 | 92 | 89 | |
| Diluted (in shares) | 90 | 95 | 101 | 100 | 100 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 112 | 162 | 97 | 120 | 91 | |
| Marketable securities | 198 | 66 | 274 | 69 | 28 | |
| Accounts receivable, net of $55,659 and $56,355 of allowances at December 31, 2025 and 2024, respectively | 220 | 235 | 242 | 240 | 135 | |
| Prepaid expenses and other current assets | 21 | 9 | 27 | 4 | 5 | |
| Total current assets | 552 | 473 | 640 | 434 | 259 | |
| Property and equipment, net | 30 | 12 | 10 | 8 | 5 | |
| Operating lease right-of-use assets | 25 | 17 | 18 | 7 | 8 | |
| Goodwill | 20 | 16 | 12 | 12 | 12 | |
| Intangible assets, net | 6 | 1 | 0 | 99,000 | 599,000 | |
| Deferred tax assets, net | 93 | 85 | 73 | 78 | 71 | |
| Other noncurrent assets | 17 | 3 | 3 | 4 | 3 | |
| Total assets | 742 | 607 | 757 | 543 | 358 | |
| Accounts payable | 124 | 95 | 125 | 109 | 61 | |
| Accrued expenses and other current liabilities | 78 | 74 | 61 | 50 | 37 | |
| Total current liabilities | 202 | 169 | 186 | 160 | 99 | |
| Operating lease noncurrent liabilities | 24 | 16 | 17 | 6 | 7 | |
| Total liabilities | 226 | 185 | 203 | 166 | 106 | |
| Commitments and Contingencies (Note 15) | — | — | — | — | — | |
| Common stock, $0.0001 par value; 1,000,000,000 shares authorized; at December 31, 2025 and 2024, respectively; 99,049,485 and 97,692,891 shares issued; 83,365,696 and 85,310,698 outstanding at December 31, 2025 and 2024, respectively | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | |
| Additional paid-in capital | 701 | 582 | 462 | 350 | 255 | |
| Treasury stock, at cost, $0.0001 par value; 16,299,769 and 12,998,173 shares at December 31, 2025 and 2024, respectively | −388 | −304 | −1 | −1 | −1 | |
| Accumulated earnings | 203 | 144 | 90 | 28 | −2 | |
| Accumulated other comprehensive income | 498,000 | 39,000 | 3 | 501,000 | −93,000 | |
| Total stockholders equity | 516 | 422 | 553 | 377 | 252 | |
| Total liabilities and stockholders equity | 742 | 607 | 757 | 543 | 358 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income | 59 | 54 | 62 | 30 | 66 | |
| Deferred tax (benefit) expense | −8 | −10 | 4 | −7 | −33 | |
| Non-cash interest expense (income) | 434,000 | 0 | −34,000 | — | — | |
| Depreciation and amortization | 5 | 3 | 2 | 2 | 1 | |
| Loss on disposal of property and equipment | 100,000 | 1 | 0 | 0 | — | |
| Stock-based compensation expense | 132 | 128 | 123 | 101 | 34 | |
| Bad debt expense | 21 | 16 | 20 | 14 | 10 | |
| Net accretion of discounts on marketable securities | −866,000 | −2 | −4 | 0 | 0 | |
| Foreign currency exchange rate loss | 0 | 0 | −8,000 | 0 | 0 | |
| Accounts receivable | −5 | −10 | −22 | −119 | −69 | |
| Prepaid expenses and other current assets | −12 | 18 | −23 | 57,000 | 675,000 | |
| Accounts payable | 29 | −30 | 16 | 48 | 18 | |
| Accrued expenses and other current liabilities | 417,000 | 10 | 10 | 13 | 2 | |
| Other noncurrent assets and liabilities | −9 | 425,000 | 648,000 | −1 | −3 | |
| Net cash provided by operating activities | 210 | 179 | 189 | 80 | 26 | |
| Purchase of property and equipment, net | −18 | −5 | −4 | −3 | −2 | |
| Purchase of marketable securities | −355 | −170 | −430 | −163 | −111 | |
| Sale of marketable securities | 224 | 377 | 233 | 123 | 122 | |
| Acquisition of business, net of cash acquired | −9 | −5 | 0 | 0 | — | |
| Net cash (used in) provided by investing activities | −159 | 196 | −201 | −44 | 9 | |
| Repurchase of common stock | −82 | −300 | 0 | 0 | — | |
| Proceeds from exercise of stock options | 86,000 | 1 | 5 | 3 | 3 | |
| Issuance costs on credit facility | −3 | 0 | 0 | — | — | |
| Payment of employee taxes related to equity awards | −16 | −12 | −17 | −12 | −18 | |
| Proceeds from contributions to employee stock purchase plan | 1 | 1 | 1 | 1 | 1 | |
| Net cash used in financing activities | −99 | −310 | −11 | −8 | −14 | |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 62,000 | 1,000 | 1,000 | — | — | |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | −48 | 65 | −23 | 29 | 21 | |
| Cash paid for income taxes, net of refunds received | 55 | 40 | 6 | 133,000 | 97,000 | |
| Additions of property and equipment, net included in accounts payable and accrued expenses | 681,000 | 249,000 | 421,000 | 636,000 | 204,000 |